|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: RENAL CARE GROUP INC, 8-K, EX-27.B, 2000-10-10 |
Next: LABORATORY CORP OF AMERICA HOLDINGS, 424B1, 2000-10-10 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENTS OF RENAL CARE GROUP, INC. FOR THE
YEAR ENDED DECEMBER 31, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> DEC-31-1997
<PERIOD-START> JAN-01-1997
<PERIOD-END> DEC-31-1997
<EXCHANGE-RATE> 1
<CASH> 10,681
<SECURITIES> 3,625
<RECEIVABLES> 58,580
<ALLOWANCES> 0
<INVENTORY> 6,096
<CURRENT-ASSETS> 88,308
<PP&E> 71,937
<DEPRECIATION> 0
<TOTAL-ASSETS> 311,661
<CURRENT-LIABILITIES> 66,263
<BONDS> 0
0
0
<COMMON> 408
<OTHER-SE> 191,312
<TOTAL-LIABILITY-AND-EQUITY> 311,611
<SALES> 0
<TOTAL-REVENUES> 274,518
<CGS> 0
<TOTAL-COSTS> 189,284
<OTHER-EXPENSES> 41,152
<LOSS-PROVISION> 8,072
<INTEREST-EXPENSE> 1,976
<INCOME-PRETAX> 34,034
<INCOME-TAX> 12,736
<INCOME-CONTINUING> 21,298
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 21,298
<EPS-BASIC> 0.57
<EPS-DILUTED> 0.54
</TABLE>
|
|